Literature DB >> 19168259

Core classification of lung cancer: correlating nuclear size and mitoses with ploidy and clinicopathological parameters.

Iver Petersen1, Waleed F M Amin Kotb, Karl-Heinz Friedrich, Karsten Schlüns, Alfred Böcking, Manfred Dietel.   

Abstract

We attempted to establish a microscopy based tumour characterization providing insight into the genetics of cancer cells and in particular their DNA ploidy. The core classification defined semi-quantitative criteria for scoring the nuclear size ranging from small (core score 1) to giant nuclei (core score 4). By listing all nuclear sizes according to their relative frequencies it provided a measure for core size variability as a correlate of nuclear pleomorphism. Additionally, the mitosis size, their variability and the presence/abundance of tripolar and tetrapolar mitoses were determined. This classification was applied to 155 lung cancer samples from all major histologic types and the results were correlated with the analysis by DNA image cytometry and patient survival. The morphological assessments correlated highly significantly with the DNA ploidy parameters, e.g. small cell lung carcinomas showed the smallest values for nuclear size (mean core score of 1.18) and DNA content (DNA index mean of 2.08c) being highly significantly different from adenocarcinomas (1.95/3.10c), large cell lung carcinoma (2.00/3.26c) and squamous cell carcinoma (2.20/3.42c). In non-small cell lung carcinoma (NSCLC) in general and adenocarcinoma in particular, the core size variability correlated significantly with grading and survival. Furthermore, parameters indicative for chromosomal variability, i.e. 2c deviation index and 5c exceeding rate, were predictors of poor survival in NSCLC patients. As a complement to histologic tumour diagnosis the core classification should help to better stratify cancer subtypes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19168259     DOI: 10.1016/j.lungcan.2008.12.013

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  28 in total

1.  FGFR1 expression and gene copy numbers in human lung cancer.

Authors:  Lukas H Kohler; Masoud Mireskandari; Thomas Knösel; Annelore Altendorf-Hofmann; Almut Kunze; Andreas Schmidt; Norbert Presselt; Yuan Chen; Iver Petersen
Journal:  Virchows Arch       Date:  2012-05-31       Impact factor: 4.064

2.  Quantitative characterization of preneoplastic progression using single-cell computed tomography and three-dimensional karyometry.

Authors:  Vivek Nandakumar; Laimonas Kelbauskas; Roger Johnson; Deirdre Meldrum
Journal:  Cytometry A       Date:  2011-01       Impact factor: 4.355

Review 3.  The morphological and molecular diagnosis of lung cancer.

Authors:  Iver Petersen
Journal:  Dtsch Arztebl Int       Date:  2011-08-08       Impact factor: 5.594

Review 4.  Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS).

Authors:  Elizabeth R Tang; Andrew M Schreiner; Bradley B Pua
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 5.  International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

Review 6.  [Morphological and molecular pathology of lung cancer].

Authors:  I Petersen
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

7.  Prognostic significance of grading in lung adenocarcinoma.

Authors:  Justine A Barletta; Beow Y Yeap; Lucian R Chirieac
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

8.  [Small cell lung cancer: pathology and molecular pathology].

Authors:  K Junker; I Petersen
Journal:  Pathologe       Date:  2009-03       Impact factor: 1.011

9.  Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study.

Authors:  Jens Neumann; Friedrich Feuerhake; Gian Kayser; Thorsten Wiech; Konrad Aumann; Bernward Passlick; Paul Fisch; Martin Werner; Axel Zur Hausen
Journal:  BMC Cancer       Date:  2010-03-02       Impact factor: 4.430

Review 10.  Revisiting tumour aneuploidy - the place of ploidy assessment in the molecular era.

Authors:  Håvard E Danielsen; Manohar Pradhan; Marco Novelli
Journal:  Nat Rev Clin Oncol       Date:  2015-11-24       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.